Please select the appropriate option to comply with legal regulations

Individual Investor

This multimedia channel includes general category videos, webcasts and live broadcasts suitable for members of the public over 18 years of age and not engaged in providing investment advice. Access this channel for personal interest and information only.

Professional Investor or Financial Advisor

This multimedia channel includes investor videos and webcast presentations, live broadcasts and documents intended only for authorised and regulated professional investors and financial advisers eligible to provide investment advice to private investors.

Enter Media Channel

No reliance should be placed on the information on this site which may change without notice.
You should read the Terms & Conditions section before browsing this site.

Forgotten Password?

Device & Browser detection and switch media player for Flash & HTML5


3B PLAYER by 3B NEXUS




No video player detected. Install or upgrade your video player!

Get Video Link or the Embed Code

(with detection and switch for Flash and HTML5)
Please wait...
Please wait...

Evotec AG (EVT)

Dr. Cord Dohrmann

Chief Science Officer

Germany

Evotec – Partner of choice for oncology drug discovery.

Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies. The Company has established a unique position integrating leading technology platforms with substantial experience and expertise in key therapeutic areas including oncology to discover and develop highly differentiated therapeutics and superior biomarkers.


Please select the appropriate option to comply with legal regulations

Individual Investor

This multimedia channel includes general category videos, webcasts and live broadcasts suitable for members of the public over 18 years of age and not engaged in providing investment advice. Access this channel for personal interest and information only.

Professional Investor or Financial Advisor

This multimedia channel includes investor videos and webcast presentations, live broadcasts and documents intended only for authorised and regulated professional investors and financial advisers eligible to provide investment advice to private investors.

Enter Media Channel

No reliance should be placed on the information on this site which may change without notice.
You should read the Terms & Conditions section before browsing this site.

Search in Sort By
  • 1 2 3 of 3
  • SHOW
00:00
Evotec, Dr. Cord Dohrmann, Evotec - Partner of choice for oncology drug discovery.
00:08
, Evotec at a glance
00:15
R&D;, Profitable, revenue, growth, alliances, pipeline, Phase III, Phase II and Phase I , Leader in high quality drug discovery solutions
01:18
scientists, location, Global reach for global projects - approx. 600 scientists
02:38
alliances, biology, Metabolics, Oncology, CNS, Immunology , Drug discovery alliances & more
03:08
value chain, cell types, chemistry, Best-in-class platforms yield superior productivity
04:03
pipeline, risk, Indication, Commercials , Deep clinical pipeline without financial risk
04:46
, Experience and current oncology partners
04:50
oncology platform, Targets, Tumor metabolism, compounds, Productive oncology platform
05:36
oncology alliances, Drug discovery partners, Biomarker development , Current oncology alliances
07:20
, Examples of cancer alliances
07:25
Boehringer Ingelheim-Alliance, oncology, Milestones , Boehringer Ingelheim-Alliance Focus on cancer
08:10
Biomarkers , Response Prediction, Personalized Medicine, chemotherapy, Targeted Therapies , The future paradigm in oncology
08:50
Phospho-signatures as biomarkers, proteins, pathways, phosphorylation , Phospho-signatures as biomarkers
09:40
oncology, biomarker development, PhosphoScout, quantification of cellular phosphorylation , Roche oncology alliance
10:06
, Opportunities with Evotec
10:10
Opportunities, Drug Design platforms, Mesoscale, acetylomics, Phenotypic, Epigenetic , Leveraging Evotec expertise in oncology
10:38
, Evotec - contact info